ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 469 filers reported holding ENCOMPASS HEALTH CORP in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $211,815 | +1.7% | 2,469 | -2.1% | 0.00% | -20.0% |
| Q1 2024 | $208,349 | -35.3% | 2,523 | -47.7% | 0.01% | -58.3% |
| Q4 2023 | $322,057 | -0.7% | 4,827 | 0.0% | 0.01% | -14.3% |
| Q3 2023 | $324,181 | -0.8% | 4,827 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $326,836 | +25.2% | 4,827 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $261,141 | -9.5% | 4,827 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $288,703 | +35.5% | 4,827 | +2.5% | 0.02% | +6.7% |
| Q3 2022 | $213,000 | -19.9% | 4,709 | -0.7% | 0.02% | -37.5% |
| Q2 2022 | $266,000 | -17.9% | 4,744 | +4.1% | 0.02% | -11.1% |
| Q1 2022 | $324,000 | +11.7% | 4,556 | 0.0% | 0.03% | +8.0% |
| Q4 2021 | $290,000 | +0.7% | 4,556 | +1.3% | 0.02% | 0.0% |
| Q3 2021 | $288,000 | -19.3% | 4,496 | -0.8% | 0.02% | -24.2% |
| Q2 2021 | $357,000 | -8.7% | 4,533 | -0.3% | 0.03% | -15.4% |
| Q1 2021 | $391,000 | – | 4,548 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
| JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
| Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
| REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
| Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
| Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
| RK Capital | 115,800 | $7,525,000 | 2.13% |
| Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
| Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
| Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |